These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 19898288

  • 1. Potential application of late sodium current blockade in the treatment of heart failure and atrial fibrillation.
    Doshi D, Morrow JP.
    Rev Cardiovasc Med; 2009; 10 Suppl 1():S46-52. PubMed ID: 19898288
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillation.
    Verrier RL, Kumar K, Nieminen T, Belardinelli L.
    Europace; 2013 Mar; 15(3):317-24. PubMed ID: 23220484
    [Abstract] [Full Text] [Related]

  • 3. Is ranolazine an antiarrhythmic drug?
    Eckhardt LL, Teelin TC, January CT.
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H1989-91. PubMed ID: 18375723
    [No Abstract] [Full Text] [Related]

  • 4. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
    Sossalla S, Wagner S, Rasenack EC, Ruff H, Weber SL, Schöndube FA, Tirilomis T, Tenderich G, Hasenfuss G, Belardinelli L, Maier LS.
    J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium.
    Sossalla S, Kallmeyer B, Wagner S, Mazur M, Maurer U, Toischer K, Schmitto JD, Seipelt R, Schöndube FA, Hasenfuss G, Belardinelli L, Maier LS.
    J Am Coll Cardiol; 2010 May 25; 55(21):2330-42. PubMed ID: 20488304
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.
    Fredj S, Sampson KJ, Liu H, Kass RS.
    Br J Pharmacol; 2006 May 25; 148(1):16-24. PubMed ID: 16520744
    [Abstract] [Full Text] [Related]

  • 9. An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes.
    Song Y, Shryock JC, Belardinelli L.
    Am J Physiol Heart Circ Physiol; 2008 May 25; 294(5):H2031-9. PubMed ID: 18310511
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Too little, too late: chasing atrial fibrillation with sodium channel antagonists.
    Anderson ME.
    J Cardiovasc Electrophysiol; 2006 Jun 25; 17(6):655-6. PubMed ID: 16836717
    [No Abstract] [Full Text] [Related]

  • 12. Pathophysiology and pharmacology of the cardiac "late sodium current.".
    Zaza A, Belardinelli L, Shryock JC.
    Pharmacol Ther; 2008 Sep 25; 119(3):326-39. PubMed ID: 18662720
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.
    Burashnikov A, Di Diego JM, Barajas-Martínez H, Hu D, Cordeiro JM, Moise NS, Kornreich BG, Belardinelli L, Antzelevitch C.
    Circ Heart Fail; 2014 Jul 25; 7(4):627-33. PubMed ID: 24874201
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Electrophysiologic changes in heart failure: focus on pacemaker channels.
    Sartiani L, Stillitano F, Cerbai E, Mugelli A.
    Can J Physiol Pharmacol; 2009 Feb 25; 87(2):84-90. PubMed ID: 19234571
    [Abstract] [Full Text] [Related]

  • 17. Role of late sodium channel current block in the management of atrial fibrillation.
    Burashnikov A, Antzelevitch C.
    Cardiovasc Drugs Ther; 2013 Feb 25; 27(1):79-89. PubMed ID: 23108433
    [Abstract] [Full Text] [Related]

  • 18. The role of late I and antiarrhythmic drugs in EAD formation and termination in Purkinje fibers.
    Fedida D, Orth PM, Hesketh JC, Ezrin AM.
    J Cardiovasc Electrophysiol; 2006 May 25; 17 Suppl 1():S71-S78. PubMed ID: 16686685
    [Abstract] [Full Text] [Related]

  • 19. Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current.
    Undrovinas AI, Belardinelli L, Undrovinas NA, Sabbah HN.
    J Cardiovasc Electrophysiol; 2006 May 25; 17 Suppl 1(Suppl 1):S169-S177. PubMed ID: 16686675
    [Abstract] [Full Text] [Related]

  • 20. The electrophysiological properties of ranolazine: a metabolic anti-ischemic drug or an energy-efficient antiarrhythmic agent?
    Cingolani E, Lepor NE, Singh BN.
    Rev Cardiovasc Med; 2011 May 25; 12(3):136-42. PubMed ID: 22080924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.